Raymond James & Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.99M | Buy |
14,915
+1,179
| +9% | +$374K | ﹤0.01% | 1660 |
|
|
2024
Q2 | $3.75M | Sell |
13,736
-313
| -2% | -$91K | ﹤0.01% | 1790 |
|
|
2024
Q1 | $4.86M | Buy |
14,049
+966
| +7% | +$318K | ﹤0.01% | 1601 |
|
|
2023
Q4 | $4.22M | Sell |
13,083
-21,649
| -62% | -$6.79M | ﹤0.01% | 1644 |
|
|
2023
Q3 | $12.4M | Buy |
34,732
+767
| +2% | +$296K | 0.01% | 913 |
|
|
2023
Q2 | $12.9M | Buy |
33,965
+4,438
| +15% | +$1.81M | 0.01% | 915 |
|
|
2023
Q1 | $14.1M | Buy |
29,527
+1,627
| +6% | +$762K | 0.01% | 841 |
|
|
2022
Q4 | $11.7M | Buy |
27,900
+3,278
| +13% | +$1.32M | 0.01% | 910 |
|
|
2022
Q3 | $10.3M | Buy |
24,622
+4,540
| +23% | +$2.26M | 0.01% | 952 |
|
|
2022
Q2 | $9.94M | Buy |
20,082
+1,176
| +6% | +$612K | 0.01% | 986 |
|
|
2022
Q1 | $10.6M | Sell |
18,906
-2,665
| -12% | -$1.61M | 0.01% | 1033 |
|
|
2021
Q4 | $16.3M | Sell |
21,571
-1,813
| -8% | -$1.36M | 0.01% | 850 |
|
|
2021
Q3 | $17.4M | Sell |
23,384
-4,168
| -15% | -$3.12M | 0.02% | 781 |
|
|
2021
Q2 | $17.8M | Buy |
27,552
+1,332
| +5% | +$811K | 0.02% | 773 |
|
|
2021
Q1 | $15M | Buy |
26,220
+5,244
| +25% | +$3.11M | 0.02% | 811 |
|
|
2020
Q4 | $12.2M | Buy |
20,976
+7,021
| +50% | +$4M | 0.01% | 843 |
|
|
2020
Q3 | $7.19M | Buy |
13,955
+3,147
| +29% | +$1.59M | 0.01% | 1028 |
|
|
2020
Q2 | $4.88M | Buy |
10,808
+1,050
| +11% | +$463K | 0.01% | 1200 |
|
|
2020
Q1 | $3.42M | Buy |
9,758
+297
| +3% | +$109K | 0.01% | 1260 |
|
|
2019
Q4 | $3.5M | Buy |
9,461
+143
| +2% | +$50.4K | ﹤0.01% | 1489 |
|
|
2019
Q3 | $3.1M | Buy |
9,318
+1,374
| +17% | +$448K | ﹤0.01% | 1531 |
|
|
2019
Q2 | $2.48M | Buy |
7,944
+89
| +1% | +$26.6K | ﹤0.01% | 1667 |
|
|
2019
Q1 | $2.4M | Buy |
7,855
+2,367
| +43% | +$639K | ﹤0.01% | 1643 |
|
|
2018
Q4 | $1.27M | Sell |
5,488
-819
| -13% | -$220K | ﹤0.01% | 1946 |
|
|
2018
Q3 | $1.97M | Sell |
6,307
-781
| -11% | -$242K | ﹤0.01% | 1820 |
|
|
2018
Q2 | $2.04M | Sell |
7,088
-1,502
| -17% | -$415K | ﹤0.01% | 1741 |
|
|
2018
Q1 | $2.15M | Buy |
8,590
+21
| +0.2% | +$5.35K | ﹤0.01% | 1657 |
|
|
2017
Q4 | $2.04M | Buy |
8,569
+244
| +3% | +$59.1K | ﹤0.01% | 1675 |
|
|
2017
Q3 | $1.85M | Sell |
8,325
-20
| -0.2% | -$4.5K | ﹤0.01% | 1696 |
|
|
2017
Q2 | $1.89M | Sell |
8,345
-151
| -2% | -$32.9K | ﹤0.01% | 1609 |
|
|
2017
Q1 | $1.69M | Sell |
8,496
-2,543
| -23% | -$490K | ﹤0.01% | 1635 |
|
|
2016
Q4 | $2.01M | Sell |
11,039
-186
| -2% | -$31.7K | 0.01% | 1483 |
|
|
2016
Q3 | $1.84M | Buy |
11,225
+193
| +2% | +$29.3K | 0.01% | 1505 |
|
|
2016
Q2 | $1.58M | Sell |
11,032
-416
| -4% | -$59.3K | ﹤0.01% | 1463 |
|
|
2016
Q1 | $1.56M | Buy |
11,448
+85
| +0.7% | +$11.2K | 0.01% | 1430 |
|
|
2015
Q4 | $1.58M | Sell |
11,363
-249
| -2% | -$34.5K | 0.01% | 1394 |
|
|
2015
Q3 | $1.56M | Sell |
11,612
-2,712
| -19% | -$390K | 0.01% | 1349 |
|
|
2015
Q2 | $2.16M | Buy |
14,324
+3,452
| +32% | +$494K | 0.01% | 1276 |
|
|
2015
Q1 | $1.47M | Sell |
10,872
-400
| -4% | -$49.6K | 0.01% | 1432 |
|
|
2014
Q4 | $1.36M | Buy |
+11,272
| New | +$1.3M | 0.01% | 1384 |
|
Other funds holding BIO
VAM
